News

Recent news about Panacea Venture and select portfolio companies

September 21, 2023

Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function

September 21, 2023

Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function

September 20, 2023

Day Zero Diagnostics Announces Completion of $16M Financing Round

DZD, an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today the recent completion of a $16M round of financing. This latest financing brings the total raised by Day Zero Diagnostics to $49M in venture capital funding and over $18M in non-dilutive funding.

September 20, 2023

Day Zero Diagnostics Announces Completion of $16M Financing Round

DZD, an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today the recent completion of a $16M round of financing. This latest financing brings the total raised by Day Zero Diagnostics to $49M in venture capital funding and over $18M in non-dilutive funding.

September 20, 2023

Chime Biologics Enters into a Strategic Cooperation agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch

September 20, 2023

Chime Biologics Enters into a Strategic Cooperation agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch

September 19, 2023

Chime Biologics

September 19, 2023

Chime Biologics

September 19, 2023

Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development

September 19, 2023

Chime Biologics Announced Global Strategic Cooperation with Panolos Bioscience to Advance Multi-specific Therapeutic Proteins Development